Bad news for the economy may be good news for the Vanguard S&P 500 ETF (NYSEMKT: VOO), which will seek to notch its eight ...

Moderna faces revenue declines, regulatory setbacks, and market challenges as COVID-19 vaccine demand wanes. Learn more about ...

At the University of British Columbia, the Blakney Lab is focused on developing vaccines and therapies using self-amplifying ...

Moderna (MRNA) was in focus Thursday morning after the vaccine maker announced plans to expand its cost efficiency and ...

Biotechnology company Moderna (NASDAQ:MRNA) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 35.3% ...

Because of misunderstanding about mRNA technology, there is a move, through legislation, to limit the use of it in several states, including right here in Texas.

HealthDay News — On Tuesday, the US Department of Health and Human Services (HHS) announced that the government will invest $176 million in Moderna to expedite the creation of a pandemic influenza ...

Marvin S. Hausman MD to discuss screening program at ASCO MIAMI, FLORIDA / ACCESS Newswire / April 29, 2025 / Ludwig Enterprises, Inc. (the "Company") today announced the acceptance for publication in ...

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines ...

It is still being sold under emergency use authorization — unlike mRNA vaccines made by Pfizer and Moderna that ... Sign up ...